K. C. Pereira et al. / Tetrahedron Letters 55 (2014) 1729–1732
1731
moiety increased the coupling yield, as evidenced by comparing
H
H
N
N
N
N
H
H
H
compounds 2, 5, 16, and 17, and electron withdrawing functional-
ities on the benzimidazole (9) seemed to hinder coupling. When
comparing electron rich and electron poor arene coupling partners,
there appeared no significant trend in reactivity. The starting
materials for products 8, 9, and 13 were synthesized in inseparable
mixtures, thus the cyclization reactions produced mixtures of
H
H
KH/KD = 1.03
H
+
H
D
+
same conditions
as before
D
N
N
D
D
D
D
N
D
N
D
isomers. The cyclization was successful in forming
a new
D
D
D
six-membered ring, compound 21, but failed to couple compounds
19 and 20, which would have produced seven membered rings.
This indicated that the length of the tether highly influenced the
success of the reaction.
D
D
Scheme 2. KIE study of the intramolecular benzimidazole-arene CDC.19
Intramolecular coupling reactions between benzimidazole and
other heterocycles, such as furan, imidazole, and the caffeine deriv-
ative, benzyl theophylline, were also tried under our optimized
conditions; however, the attempts were unsuccessful (12, 14, and
22, Table 2).
Kinetic isotope effects of the reaction were evaluated by carry-
ing out competition studies. The first competition study employed
equimolar amounts of N-benzylbenzimidazole and deuterated
N-benzyl-d7-benzimidazole, and subjected both substrates to the
optimized coupling conditions. Relative amounts of the products
were obtained from GC–MS analysis and a KIE of 1.03 was obtained
(Scheme 2). This indicated that the metalation of the arene
coupling partner was facile and not rate limiting.18 A second
competition study was carried out with equimolar amounts of
N-benzylbenzimidazole and N-benzyl-2-deuterobenzimidazole,
but the KIE results of this test proved to be inconclusive due to
H/D scrambling.
With the KIE studies in hand, we sought to propose a plausible
mechanism for this unique intramolecular CDC reaction. Based on
all data, it seemed that the coupling was taking place through a
PdII/CuI catalyzed system. Our reasoning behind the dual metal
catalysis was supported by several factors. It was known from
previous studies that Cu(I) was capable of enhancing azole
coupling,8–11 so we speculated that Cu(I) was needed to activate
the C2 position of the benzimidazole. Because the addition of
Cu(I) only raised the percent yield slightly (Table 1, entry 10), we
needed to be sure that the addition of Cu(I) was essential in the
formation of the product. Since the Cu(OAc)2 oxidant could dispro-
portionate into Cu(I), we theorized that there was perhaps some
Cu(I) present to catalyze the reaction even in the absence of added
CuOAc. This would explain why we did not see a significant raise in
yield upon the addition of a Cu(I) source.
N
N
20mol % Pd(OAc)2
2 equiv AgOAc
.
+
4
AcO
3
Both reaction have
low conversion.
Only detected
N
N
products shown.
Bn
1
N
N
Bn
N
20 mol % CuI
N
2 equiv AgOAc
4
Scheme 3. Control reactions using AgOAc as an oxidant.19
N
N
Cu(OAc)2
CuOAc
N
H
2
Pd0
N
reductive
1
oxidation
elimination
H
electrophilic
metallation
N
Pd
Pd(OAc)2
N
AcOH
transmet-
alation
electrophilic
metallation
N
N
Cu
H
N
N
Cu
CuOAc
AcOH
AcOPd
To further test whether Cu(I) was involved in the mechanism,
we had to eliminate the use of Cu(OAc)2 as an oxidant (Scheme 3).
A control reaction was carried out using AgOAc as an oxidant and
Pd(OAc)2 as the only catalyst. The GC–MS results showed that
there was low conversion of the starting material into a small
amount of the acetoxylated product 3 and dimer 4. None of the
desired arylation product 2 was observed, though it is the presumed
precursor of 3. This indicated that the Pd(II) catalyst was capable of
metallating both the C2 position of the benzimidazole and the
ortho carbon of the tethered arene. However, the low conversion
indicated that this process, involving two C–H palladations, was
not likely the mechanism by which the reactions shown in Table 2
occurred.
We next ran a second control using only a Cu(I) catalyst and
AgOAc as the oxidant. The GC–MS results showed there was a
low conversion of the starting material into the dimer 4 (Scheme 3).
Consequently, we concluded that Cu(I) could activate the benz-
imidazole moiety and form the benzimidazole dimer. This control
reaction also indicated that Pd played a pivotal role in the activa-
tion of the arene for coupling.
Scheme 4. Proposed mechanism for the Pd(II)/Cu(I) catalyzed cyclization of
N-benzylbenzimdazoles.
benzimidazole, forming acetic acid and a Cu(I)-benzimidazole
complex. Next, the arene is palladated, again producing acetic acid
as a byproduct. At this point, a transmetalation could occur in
which CuOAc is released and a biaryl Pd(II) complex is formed.
The final step of the reaction would include a simple reductive
elimination to form the coupled aryl-benzimidazole product and
Pd(0). Subsequent oxidation of the Pd by the Cu(OAc)2 oxidant
would regenerate both the Pd(II) and Cu(I) catalysts. To our
knowledge, two independent C–H activations by different metals
followed by a transmetalation, is an intriguing mechanism, and
would warrant future investigations.
In conclusion, we have developed an intramolecular coupling
reaction between the 2-position of benzimidazole and a tethered
arene to form fused polycyclic heterocycles. The use of cross-dehy-
drogenative coupling in this reaction makes it highly atom
economical and cost efficient, since no prefunctionalization is
required. Mechanistic investigations led us to propose that the
reaction proceeds via a dual PdII/CuI catalyst system with a
Our proposed mechanism (Scheme 4) utilizes two independent
metalation steps. First, Cu(I) inserts in the 2-position of